Belite Bio (BLTE) Gains from Investment Securities (2020 - 2025)
Belite Bio's quarterly Gains from Investment Securities came in at $23829.0 in Q4 2025, down 98.13% year-on-year from $1.3 million in Q4 2024, and down 98.13% quarter-over-quarter from $1.3 million in Q4 2024.
Belite Bio has reported Gains from Investment Securities for 6 years, with the latest figure at $23829.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities fell 98.13% year-over-year to $23829.0; the trailing twelve-month figure through Dec 2025 stood at $23829.0 (down 98.13% YoY), and the FY2025 full-year result was $23829.0, down 98.13% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at $23829.0, down from $1.3 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $3.6 million in Q4 2022, with the low at $23829.0 in Q4 2025.
- Average Gains from Investment Securities over 5 years is $1.4 million, with a median of $1.3 million recorded in 2024.
- Year-over-year, Gains from Investment Securities slumped 98.83% in 2023 and soared 2935.71% in 2024.
- Tracing BLTE's Gains from Investment Securities over 5 years: stood at $2.0 million in 2021, then surged by 80.39% to $3.6 million in 2022, then tumbled by 98.83% to $42000.0 in 2023, then soared by 2935.71% to $1.3 million in 2024, then sank by 98.13% to $23829.0 in 2025.
- The last three Gains from Investment Securities figures came in at $23829.0 (Q4 2025), $1.3 million (Q4 2024), and $42000.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Belite Bio | 4.92 Bn | 4.45 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Dec 31, 2024 | -8,000.00 |
| Dec 31, 2024 | -8,000.00 |
| Dec 31, 2023 | 42,000.00 |
| Dec 31, 2023 | 42,000.00 |
| Dec 31, 2022 | 3.58 Mn |
| Dec 31, 2022 | 3.58 Mn |
| Dec 31, 2021 | 1.98 Mn |
| Dec 31, 2021 | 1.98 Mn |
| Dec 31, 2020 | 3.40 Mn |
| Dec 31, 2020 | 3.40 Mn |